Monoclonal antibody therapy in inflammatory bowel disease.
Vasiliauskas
E A
EA
Inflammatory Bowel Disease Center, Divisions of Gastroenterology and Pediatric Gastroenterology, Departments of Medicine and Pediatrics, Cedars-Sinai Medical Center, Los Angeles, Calif., USA.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000276:immunology / Q000628:therapy*; D007408:Intestinal Absorption; D012449:Safety; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha